- Home
- MBOT vs COYA Comparison
MBOT vs COYA Comparison
Compare MBOT & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBOT | COYA |
|---|---|---|
| Founded | 2010 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.7M | 126.6M |
| IPO Year | 2000 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MBOT | COYA |
|---|---|---|
| Price | $2.39 | $3.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $7.50 | ★ $15.80 |
| AVG Volume (30 Days) | ★ 1.4M | 113.8K |
| Earning Date | 03-26-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.27 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $116,887.00 | ★ $7,945,753.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4,200.00 | $820.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 123.57 |
| 52 Week Low | $1.35 | $3.94 |
| 52 Week High | $4.62 | $7.75 |
Technical Indicators
Market Signals| Indicator | MBOT | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 46.46 | 30.73 |
| Support Level | $2.34 | $3.94 |
| Resistance Level | $2.64 | $5.16 |
| Average True Range (ATR) | 0.15 | 0.25 |
| MACD | -0.04 | -0.05 |
| Stochastic Oscillator | 8.91 | 8.73 |
Price Performance
Historical ComparisonAbout MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.